1
|
Buttura da Prato E, Molina B, Tanzini L, Cigni C, Bellia G. A Personalized Protocol for Facial Rejuvenation Using Two Soft Hyaluronic Acid Fillers With High Cohesivity. PLASTIC AND AESTHETIC NURSING 2024; 44:E8-E16. [PMID: 39348313 DOI: 10.1097/psn.0000000000000597] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/02/2024]
Abstract
Minimally invasive injectable dermal fillers are one of the most commonly used aesthetic treatments for facial soft tissue restoration. Different formulations may be used simultaneously to target multiple areas of concern. Due to differences in their rheological properties that directly impact the recommended injection technique and overall result, the formulations in the Aliaxin® line are each designed to target different soft facial tissues. This case series addresses two potential treatment approaches and a combination approach specifically developed to achieve harmony and promote a full but soft facial appearance. To reach this goal, we used two different formulations: Aliaxin® Shape and Restore (ASR) and Aliaxin® Global Performance (AGP). Four patients, 35-55 years received treatments with ASR, AGP, or both products. Utilizing the two protocols simultaneously achieved targeted support, lift, and volume, along with effective full facial softening and an authentic aesthetic outcome.
Collapse
Affiliation(s)
- Editta Buttura da Prato
- Editta Buttura da Prato, MD, Private Practice, Verona, Italy
- Beatriz Molina, MD, Medikas Clinic, 5 Vestry Road, Somerset, Bristol, UK
- Laura Tanzini, MSc, IBSA Farmaceutici Italia Srl, Lodi, Italy
- Clara Cigni, PhD, IBSA Farmaceutici Italia Srl, Lodi, Italy
- Gilberto Bellia, PharmD, IBSA Farmaceutici Italia Srl, Lodi, Italy
| | - Beatriz Molina
- Editta Buttura da Prato, MD, Private Practice, Verona, Italy
- Beatriz Molina, MD, Medikas Clinic, 5 Vestry Road, Somerset, Bristol, UK
- Laura Tanzini, MSc, IBSA Farmaceutici Italia Srl, Lodi, Italy
- Clara Cigni, PhD, IBSA Farmaceutici Italia Srl, Lodi, Italy
- Gilberto Bellia, PharmD, IBSA Farmaceutici Italia Srl, Lodi, Italy
| | - Laura Tanzini
- Editta Buttura da Prato, MD, Private Practice, Verona, Italy
- Beatriz Molina, MD, Medikas Clinic, 5 Vestry Road, Somerset, Bristol, UK
- Laura Tanzini, MSc, IBSA Farmaceutici Italia Srl, Lodi, Italy
- Clara Cigni, PhD, IBSA Farmaceutici Italia Srl, Lodi, Italy
- Gilberto Bellia, PharmD, IBSA Farmaceutici Italia Srl, Lodi, Italy
| | - Clara Cigni
- Editta Buttura da Prato, MD, Private Practice, Verona, Italy
- Beatriz Molina, MD, Medikas Clinic, 5 Vestry Road, Somerset, Bristol, UK
- Laura Tanzini, MSc, IBSA Farmaceutici Italia Srl, Lodi, Italy
- Clara Cigni, PhD, IBSA Farmaceutici Italia Srl, Lodi, Italy
- Gilberto Bellia, PharmD, IBSA Farmaceutici Italia Srl, Lodi, Italy
| | - Gilberto Bellia
- Editta Buttura da Prato, MD, Private Practice, Verona, Italy
- Beatriz Molina, MD, Medikas Clinic, 5 Vestry Road, Somerset, Bristol, UK
- Laura Tanzini, MSc, IBSA Farmaceutici Italia Srl, Lodi, Italy
- Clara Cigni, PhD, IBSA Farmaceutici Italia Srl, Lodi, Italy
- Gilberto Bellia, PharmD, IBSA Farmaceutici Italia Srl, Lodi, Italy
| |
Collapse
|
2
|
Micheels P, Porcello A, Bezzola T, Perrenoud D, Christen MO, Applegate LA, Laurent A. Comprehensive Evaluation of Injectability Attributes in OxiFree™ Dermal Fillers: MaiLi ® Product Variants and Clinical Case Reports. Gels 2024; 10:276. [PMID: 38667695 PMCID: PMC11049332 DOI: 10.3390/gels10040276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2024] [Revised: 04/08/2024] [Accepted: 04/16/2024] [Indexed: 04/28/2024] Open
Abstract
Dermal filler injectability is a critical factor for commercial product adoption by medical aesthetic professionals and for successful clinical administration. We have previously reported (in vitro and ex vivo) cross-linked hyaluronic acid (HA)-based dermal filler benchmarking in terms of manual and automated injectability requirements. To further enhance the function-oriented product characterization workflows and the clinical relevance of dermal filler injectability assessments, the aim of this study was to perform in vivo evaluations. Therefore, several variants of the MaiLi® product range (OxiFree™ technology) were characterized in vitro and in vivo in terms of injectability attributes, with a focus on hydrogel system homogeneity and ease of injection. Firstly, standardized in vitro assays were performed in SimSkin® cutaneous equivalents, with variations of the clinical injector, injection site, and injection technique. Then, automated injections in SimSkin® cutaneous equivalents were comparatively performed in a texture analysis setup to obtain fine-granulometry injection force profile results. Finally, five female participants were recruited for the in vivo arm of the study (case reports), with variations of the clinical injector, injection site, and injection technique. Generally, the obtained quantitative force values and injection force profiles were critically appraised from a translational viewpoint, based on discussions around the OxiFree™ manufacturing technology and on in-use specialized clinician feedback. Overall, the present study outlined a notable level of homogeneity across the MaiLi® product range in terms of injectability attributes, as well as consistently high ease of administration by medical aesthetic clinicians.
Collapse
Affiliation(s)
| | - Alexandre Porcello
- Development Department, Abcello Sàrl, CH-1432 Belmont-sur-Yverdon, Switzerland;
| | | | | | | | - Lee Ann Applegate
- Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, CH-1066 Epalinges, Switzerland;
- Center for Applied Biotechnology and Molecular Medicine, University of Zurich, CH-8057 Zurich, Switzerland
- Oxford OSCAR Suzhou Center, Oxford University, Suzhou 215123, China
| | - Alexis Laurent
- Regenerative Therapy Unit, Lausanne University Hospital, University of Lausanne, CH-1066 Epalinges, Switzerland;
- Manufacturing Department, TEC-PHARMA SA, CH-1038 Bercher, Switzerland
- Manufacturing Department, LAM Biotechnologies SA, CH-1066 Epalinges, Switzerland
| |
Collapse
|
3
|
Zhou W, Hou S, Deng S, Peng Y, Fu W, Zhou Y, Yang J, Peng C. The Intrinsic Relation between the Hydrogel Structure and In Vivo Performance of Hyaluronic Acid Dermal Fillers: A Comparative Study of Four Typical Dermal Fillers. Tissue Eng Regen Med 2023; 20:503-517. [PMID: 37041433 PMCID: PMC10219904 DOI: 10.1007/s13770-023-00533-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2022] [Revised: 02/18/2023] [Accepted: 02/20/2023] [Indexed: 04/13/2023] Open
Abstract
BACKGROUND Hyaluronic acid dermal fillers are composed of cross-linked viscoelastic particles with high biocompatibility. The performance of the fillers is determined by the viscoelastic properties of particles and the connecting force between particles. However, the relationships among the properties of fillers, the interaction of the gels and the surrounding tissue are not clear enough. METHOD Four kinds of typical dermal filler were selected in this research to reveal the interaction between the gels and cells. A series of analytical tools was applied to characterize the structure and physicochemical properties of the gel, as well as observing their interaction with the surrounding tissues in vivo and discussing their internal mechanism. RESULT The large particles internal the gel and the high rheological properties endow the Restylane2 with excellent support. However, these large-size particles have a significant impact on the metabolism of the local tissue surrounding the gel. Juvéderm3 present gel integrity with the high cohesiveness and superior support. The rational matching of large and small particles provides the Juvéderm3 with supporting capacity and excellent biological performance. Ifresh is characterized by small-size particles, moderate cohesiveness, good integrity, lower viscoelasticity and the superior cellular activity located the surrounding tissues. Cryohyaluron has high cohesion and medium particle size and it is prominent in cell behaviors involving localized tissues. Specific macroporous structure in the gel may facilitate the nutrients delivering and removing the waste. CONCLUSION It's necessary to make the filler both sufficient support and biocompatibility through the rational matching of particle sizes and rheological properties. Gels with macroporous structured particle showed an advantage in this area by providing a space inside the particle.
Collapse
Affiliation(s)
- Weiwei Zhou
- Department of Stomatology, The Second Hospital of Tianjin Medical University, 22 Pingjiang Road, Hexi District, Tianjin, 300211, China
| | - Shuai Hou
- Department of Stomatology, General Hospital, Tianjin Medical University, 154 Anshan Road, Heping District, Tianjin, 300052, China
| | - Shu Deng
- The Forsyth Institute/Harvard University School of Dental Medicine, 245 First Street, Cambridge, MA, 02142, USA
| | - Yang Peng
- National Engineering Laboratory for Digital and Material Technology of Stomatology Center of Digital Dentistry Peking University School and Hospital of Stomatology, Beijing, 100081, China
| | - Wei Fu
- Department of Stomatology, The Second Hospital of Tianjin Medical University, 22 Pingjiang Road, Hexi District, Tianjin, 300211, China
| | - Yang Zhou
- Department of Stomatology, General Hospital, Tianjin Medical University, 154 Anshan Road, Heping District, Tianjin, 300052, China
| | - Jie Yang
- Department of Stomatology, The Second Hospital of Tianjin Medical University, 22 Pingjiang Road, Hexi District, Tianjin, 300211, China.
| | - Cheng Peng
- Department of Stomatology, The Second Hospital of Tianjin Medical University, 22 Pingjiang Road, Hexi District, Tianjin, 300211, China.
| |
Collapse
|
4
|
Scrima M, Merola F, Vito N, Pacchioni D, Vecchi G, Melito C, Iorio A, Giori AM, Ferravante A. Elucidations on the Performance and Reversibility of Treatment with Hyaluronic Acid Based Dermal Fillers: In vivo and in vitro Approaches. Clin Cosmet Investig Dermatol 2022; 15:2629-2640. [PMID: 36523543 PMCID: PMC9744867 DOI: 10.2147/ccid.s383354] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2022] [Accepted: 10/25/2022] [Indexed: 08/26/2023]
Abstract
Purpose The aim of this study was to investigate the performance and the reversibility of different classes of Hyaluronic Acid (HA) dermal fillers. We analysed 4 HA based fillers, belonging to 3 different chemical classes of products, commonly used in the field of wrinkles correction: linear HA 8 mg/mL (Viscoderm 0.8), thermically stabilized hybrid complexes of high and low molecular weight HA molecules at a concentration of 32 mg/mL and 45 mg/mL respectively (Profhilo and Profhilo Structura) and cross-linked HA 25 mg/mL (Aliaxin GP). Methods The products were tested by a well-established animal model. The generated implants were analyzed through High-Frequency Ultrasound technology. Then, reversibility of the treatment was evaluated by enzymatic degradation kinetics studies, characterised by a combined approach of Carbazole assay and HP-SEC/TDA method. Results Implants generated by linear HA 8 mg/mL remained detectable by ultrasound acquisition for 4 weeks, whereas those generated by injection of HA hybrid complex 32 mg/mL were detectable for 10 weeks. HA hybrid complex 45 mg/mL and cross-linked HA 25 mg/mL were detectable for 29 and at least 33 weeks, respectively. Enzymatic degradation kinetics studies demonstrated that the HA content in HA hybrid complex 45 mg/mL was almost completely depolymerized and homogeneous after 3 h of treatment. For cross-linked HA 25 mg/mL, 24 h of incubation are needed to obtain the same degree of depolymerization. Conclusion The study confirmed the ability of the experimental model to predict the behaviour of HA based dermal fillers in vivo and showed the innovative aspects of HA hybrid complex 45 mg/mL, that combines the high-safety profile, in terms of reversibility of the treatment, of the linear HA-based products with the durability of a high degree cross-linked gels, paving the way to the chance to be used for a wide range of applications in the field of aesthetic medicine.
Collapse
Affiliation(s)
- Mario Scrima
- R&D Department, - IBSA Farmaceutici Italia, Ariano Irpino, Italy
| | - Filomena Merola
- R&D Department, - IBSA Farmaceutici Italia, Ariano Irpino, Italy
| | - Nicoletta Vito
- R&D Department, - IBSA Farmaceutici Italia, Ariano Irpino, Italy
| | | | | | - Carmela Melito
- R&D Department, - IBSA Farmaceutici Italia, Ariano Irpino, Italy
| | - Antonio Iorio
- R&D Department, - IBSA Farmaceutici Italia, Ariano Irpino, Italy
| | | | | |
Collapse
|
5
|
La Gatta A, Bedini E, Aschettino M, Finamore R, Schiraldi C. Hyaluronan Hydrogels: Rheology and Stability in Relation to the Type/Level of Biopolymer Chemical Modification. Polymers (Basel) 2022; 14:polym14122402. [PMID: 35745978 PMCID: PMC9228881 DOI: 10.3390/polym14122402] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2022] [Revised: 06/08/2022] [Accepted: 06/09/2022] [Indexed: 02/04/2023] Open
Abstract
BDDE (1,4-butanediol-diglycidylether)-crosslinked hyaluronan (HA) hydrogels are widely used for dermo-aesthetic purposes. The rheology and stability of the gels under physiological conditions greatly affect their clinical indications and outcomes. To date, no studies investigating how these features are related to the chemistry of the polymeric network have been reported. Here, four available HA-BDDE hydrogels were studied to determine how and to what extent their rheology and stability with respect to enzymatic hydrolysis relate to the type and degree of HA structural modification. 1H-/13C-NMR analyses were associated for the quantification of the “true” HA chemical derivatization level, discriminating between HA that was effectively crosslinked by BDDE, and branched HA with BDDE that was anchored on one side. The rheology was measured conventionally and during hydration in a physiological medium. Sensitivity to bovine testicular hyaluronidase was quantified. The correlation between NMR data and gel rheology/stability was evaluated. The study indicated that (1) the gels greatly differed in the amounts of branched, crosslinked, and overall modified HA, with most of the HA being branched; (2) unexpectedly, the conventionally measured rheological properties did not correlate with the chemical data; (3) the gels’ ranking in terms of rheology was greatly affected by hydration; (4) the rheology of the hydrated gels was quantitatively correlated with the amount of crosslinked HA, whereas the correlations with the total HA modification level and with the degree of branched HA were less significant; (5) increasing HA derivatization/crosslinking over 9/3 mol% did not enhance the stability with respect to hyaluronidases. These results broaden our knowledge of these gels and provide valuable information for improving their design and characterization.
Collapse
Affiliation(s)
- Annalisa La Gatta
- Department of Experimental Medicine, School of Medicine, University of Campania “Luigi Vanvitelli”, Via L. De Crecchio 7, 80138 Naples, Italy; (M.A.); (R.F.); (C.S.)
- Correspondence:
| | - Emiliano Bedini
- Department of Chemical Sciences, University of Naples Federico II, Via Cintia 4, 80126 Naples, Italy;
| | - Maria Aschettino
- Department of Experimental Medicine, School of Medicine, University of Campania “Luigi Vanvitelli”, Via L. De Crecchio 7, 80138 Naples, Italy; (M.A.); (R.F.); (C.S.)
| | - Rosario Finamore
- Department of Experimental Medicine, School of Medicine, University of Campania “Luigi Vanvitelli”, Via L. De Crecchio 7, 80138 Naples, Italy; (M.A.); (R.F.); (C.S.)
| | - Chiara Schiraldi
- Department of Experimental Medicine, School of Medicine, University of Campania “Luigi Vanvitelli”, Via L. De Crecchio 7, 80138 Naples, Italy; (M.A.); (R.F.); (C.S.)
| |
Collapse
|
6
|
de la Guardia C, Virno A, Musumeci M, Bernardin A, Silberberg MB. Rheologic and Physicochemical Characteristics of Hyaluronic Acid Fillers: Overview and Relationship to Product Performance. Facial Plast Surg 2022; 38:116-123. [PMID: 35114708 PMCID: PMC9188840 DOI: 10.1055/s-0041-1741560] [Citation(s) in RCA: 34] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
Injections with hyaluronic acid (HA) fillers for facial rejuvenation and soft-tissue augmentation are among the most popular aesthetic procedures worldwide. Many HA fillers are available with unique manufacturing processes and distinct in vitro physicochemical and rheologic properties, which result in important differences in the fillers' clinical performance. The aim of this paper is to provide an overview of the properties most widely used to characterize HA fillers and to report their rheologic and physicochemical values obtained using standardized methodology to allow scientifically based comparisons. Understanding rheologic and physicochemical properties will guide clinicians in aligning HA characteristics to the facial area being treated for optimal clinical performance.
Collapse
Affiliation(s)
- Carola de la Guardia
- Medical Affairs, Allergan Aesthetics, an AbbVie company, Marlow, United Kingdom of Great Britain and Northern Ireland
| | - Ada Virno
- Clinical Development, Allergan Aesthetics, an AbbVie company, Rome, Italy
| | - Maria Musumeci
- Medical Affairs, Allergan Aesthetics, an AbbVie company, Marlow, United Kingdom of Great Britain and Northern Ireland
| | | | - Michael B Silberberg
- Medical Affairs, Allergan Aesthetics, an AbbVie company, Marlow, United Kingdom of Great Britain and Northern Ireland
| |
Collapse
|
7
|
Kleine-Börger L, Meyer R, Kalies A, Kerscher M. Approach to differentiate between hyaluronic acid skin quality boosters and fillers based on their physicochemical properties. J Cosmet Dermatol 2021; 21:149-157. [PMID: 34806283 DOI: 10.1111/jocd.14629] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Accepted: 11/05/2021] [Indexed: 02/01/2023]
Abstract
BACKGROUND The clinical indications, applications, and effect of the injectable hyaluronic acid range skin quality boosters (SQBs) are different than those of filler products. Material properties are increasingly being discussed for differentiation and in connection with clinical effects and esthetic indications. AIMS The aim of this study is to evaluate whether SQB products can be differentiated from filler products by their physicochemical material properties. MATERIAL AND METHODS Physicochemical properties (extrusion force, swelling degree, rheology, and cohesivity) of two SQBs (BELR , JUVVE ) were compared with those of fillers (BELB , JUVVT ) using the same manufacturing technology. RESULTS Cohesivity was almost equal for SQBs and fillers. Few statistically significant differences in physicochemical properties were found. Properties of SQBs differed from fillers mainly in their delta of rheological properties and extrusion force. CONCLUSION In this study, physicochemical differences between SQB and filler were determined and described, supporting the presence of two categories and their different clinical indications and applications.
Collapse
Affiliation(s)
- Linda Kleine-Börger
- Cosmetic Science, Institute of Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany
| | - Robert Meyer
- Institute for Technical and Macromolecular Chemistry, University of Hamburg, Hamburg, Germany
| | | | - Martina Kerscher
- Cosmetic Science, Institute of Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany
| |
Collapse
|
8
|
Hyaluronan Hydrogels for Injection in Superficial Dermal Layers: An In Vitro Characterization to Compare Performance and Unravel the Scientific Basis of Their Indication. Int J Mol Sci 2021; 22:ijms22116005. [PMID: 34199374 PMCID: PMC8199639 DOI: 10.3390/ijms22116005] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Revised: 05/26/2021] [Accepted: 05/28/2021] [Indexed: 11/17/2022] Open
Abstract
Background: Skinboosters represent the latest category of hyaluronan (HA) hydrogels released for aesthetic purposes. Different from originally developed gels, they are intended for more superficial injections, claiming a skin rejuvenation effect through hydration and possibly prompting biochemical effects in place of the conventional volumetric action. Here, three commercial skinboosters were characterized to unravel the scientific basis for such indication and to compare their performances. Methods: Gels were evaluated for water-soluble/insoluble-HA composition, rheology, hydration, cohesivity, stability and effect, in vitro, on human dermal fibroblasts towards the production of extracellular matrix components. Results: Marked differences in the insoluble-hydrogel amount and in the hydrodynamic parameters for water-soluble-HA chains were evidenced among the gels. Hydration, rigidity and cohesivity also varied over a wide range. Sensitivity to hyaluronidases and Reactive Oxygen Species was demonstrated allowing a stability ranking. Slight differences were found in gels’ ability to prompt elastin expression and in ColIV/ColI ratio. Conclusions. A wide panel of biophysical and biochemical parameters for skinboosters was provided, supporting clinicians in the conscious tuning of their use. Data revealed great variability in gels’ behavior notwithstanding the same clinical indication and unexpected similarities to the volumetric formulations. Data may be useful to improve customization of gel design toward specific uses.
Collapse
|
9
|
Vinshtok Y, Cassuto D. Biochemical and physical actions of hyaluronic acid delivered by intradermal jet injection route. J Cosmet Dermatol 2020; 19:2505-2512. [PMID: 32799371 DOI: 10.1111/jocd.13674] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2020] [Accepted: 08/10/2020] [Indexed: 11/29/2022]
Abstract
Administration of exogenous hyaluronic acid (HA) by liquid jet injection is considered as a beneficial therapy for dermatology conditions. This paper reviews variety of the factors which would optimize the clinical output of hyaluronic acid in this treatment modality. A pneumatically accelerated jet penetrates the epidermis and spherically spreads micro-droplets of HA in the dermis without significant damage to the tissue and blood vessels. Kinetic energy of the jet activates two parallel mechanisms of action-mechanical and biological-which act synergistically to initiate and augment the regenerative effect. Jet-induced micro-trauma stimulates collagen synthesis and tissue repair without inflammation. Aside from the biophysical stimulation of dermal fibroblast, the biomolecular properties of exogenous HA provide excellent clinical results for skin atrophy, remodeling of dermal scarring, and reverse formation of fibrotic tissue. The effect is mediated by HA-specific cell receptors and depends on molecular weight and the rheological properties of HA polymer. Skin mechanical properties play a key role in predicting HA dispersion patterns. Tolerability and safety of the treatment approach are determined by the jet's physical impact on the tissue and/or by the safety profile of the injected material. Although pneumatic jet delivery of a hyaluronic acid has a limited use in clinical practice, this treatment approach has a strong potential for extended implementation in esthetic dermatology. The synergistic mechanism has significant advantages of predictable and rapid clinical outcomes with a low discomfort. Additional well-designed investigations are required for establishing a scientific foundation and guidelines for this treatment modality.
Collapse
|